Format

Send to

Choose Destination
Mediators Inflamm. 2014;2014:901902. doi: 10.1155/2014/901902. Epub 2014 Aug 13.

Role of inflammatory mediators in the pathogenesis of epilepsy.

Author information

1
Neural Plasticity Project, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan.
2
Medical Research Institute, Tokyo Women's Medical University, Shinjuku, Tokyo 162-8666, Japan.

Abstract

Epilepsy is one of the most common chronic brain disorders worldwide, affecting 1% of people across different ages and backgrounds. Epilepsy is defined as the sporadic occurrence of spontaneous recurrent seizures. Accumulating preclinical and clinical evidence suggest that there is a positive feedback cycle between epileptogenesis and brain inflammation. Epileptic seizures increase key inflammatory mediators, which in turn cause secondary damage to the brain and increase the likelihood of recurrent seizures. Cytokines and prostaglandins are well-known inflammatory mediators in the brain, and their biosynthesis is enhanced following seizures. Such inflammatory mediators could be therapeutic targets for the development of new antiepileptic drugs. In this review, we discuss the roles of inflammatory mediators in epileptogenesis.

PMID:
25197169
PMCID:
PMC4147258
DOI:
10.1155/2014/901902
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center